Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1400594

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1400594

Coenzyme Q10 Market Size - By Application (Pharmaceuticals, Dietary Supplements, Cosmetics), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Global Forecast, 2023-2032

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Coenzyme Q10 Market will witness over 10.5% CAGR between 2023 and 2032 due to burgeoning research and development in the field. With increased focus on health and wellness, studies revealing CoQ10's potential benefits in heart health, energy production, and antioxidant properties have sparked immense interest.

For instance, in November 2023, A recent review article titled "Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases," penned by a team of Iranian researchers and published in Biochemistry Research International, suggested that Coenzyme Q10 (CoQ10), an intrinsic antioxidant present in the body and certain foods, could potentially aid in treating conditions like Friedreich's ataxia and other neurological ailments. The researchers propose that CoQ10's antioxidative and energy-regulating properties might safeguard the neurological system from degeneration and decline.

This surge in exploration fuels demand, compelling industries to innovate and enhance CoQ10 formulations for wider applications. As scientific endeavors unravel its multifaceted advantages, the market growth trajectory aligns with the quest for improved health solutions in modern times.

The overall Coenzyme Q10 Market share is classified based on application and region.

Coenzyme Q10 market size from the pharmaceuticals segment will register a noteworthy CAGR from 2023 to 2032. Pharmaceutical industries value CoQ10 for its role in treating cardiovascular issues, neurological disorders, and potential applications in cancer treatment. With its antioxidant properties and involvement in cellular energy production, CoQ10 holds promise in enhancing drug formulations and supplementing various therapies. This escalating demand within pharmaceuticals reflects the continuous exploration and utilization of CoQ10 as a vital component in advancing medical interventions for improved health outcomes.

Asia Pacific coenzyme Q10 industry will showcase a commendable CAGR from 2023 to 2032. With rising awareness of preventive healthcare, there is a surge in CoQ10 consumption in dietary supplements and cosmetics. This trend is propelled by its antioxidant properties and purported benefits in heart health. Moreover, Asia Pacific's aging population seeks CoQ10 for its potential in addressing age-related health concerns.

This increasing demand reflects the region's inclination toward holistic health practices, driving the CoQ10 market growth across diverse industries. For instance, in August 2021, Kaneka Corporation, led by President Minoru Tanaka and headquartered in Minato-ku, Tokyo, declared that the active variant of Coenzyme Q10 demonstrates efficacy in alleviating transient fatigue. Recent functional claims endorse its ability to enhance sleep quality amidst temporary stress, reduce such stress, and aid in sustaining oral moisture. Consequently, Kaneka Your Health Care Co., Ltd., helmed by President Shoji Nagae and also based in Minato-ku, Tokyo, introduced a novel product line named "Watashi no ChikaraTM," featuring these functional benefits.

Product Code: 741

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Global coenzyme Q10 industry 360 degree synopsis, 2023 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Application trend

Chapter 3 Global coenzyme Q10 Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Impact of COVID-19 on world economy
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Vendor matrix
    • 3.3.2 Distribution channel analysis
      • 3.3.2.1 Distributor
      • 3.3.2.2 Suppliers
      • 3.3.2.3 Contract Manufacturing
      • 3.3.2.4 Technology providers
  • 3.4 Raw material analysis: Covid-19 impact on supply
    • 3.4.1 Covid-19 impact on supply
  • 3.5 Industry landscape, 2018 - 2032
  • 3.6 Technology landscape
  • 3.7 Regulatory landscape
    • 3.7.1 Europe
  • 3.8 Pricing analysis
      • 3.8.1.1 Regional pricing: COVID-19 impact
      • 3.8.1.2 Cost structure analysis
  • 3.9 Industry impact forces
    • 3.9.1 Growth drivers
      • 3.9.1.1 North America: Growing demand for cosmetics product
      • 3.9.1.2 Europe: Increasing prevalence of diabetes and cardiovascular diseases
      • 3.9.1.3 Asia Pacific: Pharmaceutical market expansion leading to rising demand
    • 3.9.2 Industry pitfalls & challenges
      • 3.9.2.1 Minimum dosage requirement
  • 3.10 Innovation & sustainability
  • 3.11 Growth potential analysis, 2022
    • 3.11.1 Emerging business model
      • 3.11.1.1 New Product Launch
      • 3.11.1.2 Collaboration
  • 3.12 Porter's analysis
    • 3.12.1 Bargaining power of suppliers
    • 3.12.2 Bargaining power of buyers
    • 3.12.3 Threat of new entrants
    • 3.12.4 Threat of substitutes
  • 3.13 Competitive landscape, 2022
    • 3.13.1 Company market share analysis, 2022
    • 3.13.2 Top players overview
    • 3.13.3 Strategy dashboard
  • 3.14 PESTEL analysis
  • 3.15 COVID-19 impact on Coenzyme Q10 demand, by application
    • 3.15.1 Dietary Supplements
    • 3.15.2 Pharmaceuticals
    • 3.15.3 Cosmetics
    • 3.15.4 Others

Chapter 4 Global Coenzyme Q 10 Market, By Application

  • 4.1 Key application trends
  • 4.2 Pharmaceuticals
    • 4.2.1 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
    • 4.2.2 Global coenzyme Q10 market from pharmaceutical application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.3 Dietary Supplements
    • 4.3.1 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
    • 4.3.2 Global coenzyme Q10 market from dietary supplements application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.4 Cosmetics
    • 4.4.1 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
    • 4.4.2 Global coenzyme Q10 market from cosmetics application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.5 Others
    • 4.5.1 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
    • 4.5.2 Global coenzyme Q10 market from other application, by region, 2018 - 2032, (Tons) (USD Million)

Chapter 5 Global Coenzyme Q 10 Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.2.2 North America coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.3.2 U.S. coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.4.2 Canada coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.3.2 Europe coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.3.2 Germany coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.4.2 UK coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.5 France
      • 5.3.5.1 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.5.2 France coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.6 Italy
      • 5.3.6.1 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.6.2 Italy coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.7 Russia
      • 5.3.7.1 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.7.2 Russia coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.8 Poland
      • 5.3.8.1 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.8.2 Poland coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.4.2 Asia Pacific coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.3.2 China coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.4.2 India coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.5 Japan
      • 5.4.5.1 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.5.2 Japan coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.5 Latin America (LATAM)
    • 5.5.1 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.5.2 LATAM coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.3.2 Brazil coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.4.2 Mexico coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.6 Middle East & Africa (MEA)
    • 5.6.1 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.6.2 MEA coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)

Chapter 6 Company Profiles

  • 6.1 Kaneka Corporation
    • 6.1.1 Business Overview
    • 6.1.2 Financial Data
    • 6.1.3 Product Landscape
    • 6.1.4 SWOT Analysis
  • 6.2 DSM
    • 6.2.1 Business Overview
    • 6.2.2 Financial Data
    • 6.2.3 Product Landscape
    • 6.2.4 SWOT Analysis
  • 6.3 SourceOne Global Partners, LLC
    • 6.3.1 Business Overview
    • 6.3.2 Financial Data
    • 6.3.3 Product Landscape
    • 6.3.4 SWOT Analysis
  • 6.4 Healthy Origins
    • 6.4.1 Business Overview
    • 6.4.2 Financial Data
    • 6.4.3 Product Landscape
    • 6.4.4 SWOT Analysis
  • 6.5 Vitamin Shoppe, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Data
    • 6.5.3 Product Landscape
    • 6.5.4 SWOT Analysis
  • 6.6 NBTY, Inc.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Data
    • 6.6.3 Product Landscape
    • 6.6.4 SWOT Analysis
  • 6.7 Pharmavite LLC
    • 6.7.1 Business Overview
    • 6.7.2 Financial Data
    • 6.7.3 Product Landscape
    • 6.7.4 SWOT Analysis
  • 6.8 QUTEN Research Institute LLC
    • 6.8.1 Business Overview
    • 6.8.2 Financial Data
    • 6.8.3 Product Landscape
    • 6.8.4 SWOT Analysis
  • 6.9 Tishcon Corp.
    • 6.9.1 Business Overview
    • 6.9.2 Financial Data
    • 6.9.3 Product Landscape
    • 6.9.4 SWOT Analysis
  • 6.10 Country Life, LLC
    • 6.10.1 Business Overview
    • 6.10.2 Financial Data
    • 6.10.3 Product Landscape
    • 6.10.4 SWOT Analysis
  • 6.11 Natural Organics
    • 6.11.1 Business Overview
    • 6.11.2 Financial Data
    • 6.11.3 Product Landscape
    • 6.11.4 SWOT Analysis
    • 6.11.5 Strategic Outlook
  • 6.12 Jarrow Formulas
    • 6.12.1 Business Overview
    • 6.12.2 Financial Data
    • 6.12.3 Product Landscape
    • 6.12.4 SWOT Analysis
  • 6.13 NOW Foods
    • 6.13.1 Business Overview
    • 6.13.2 Financial Data
    • 6.13.3 Product Landscape
    • 6.13.4 SWOT Analysis
  • 6.14 Pharma Nord, Inc.
    • 6.14.1 Business Overview
    • 6.14.2 Financial Data
    • 6.14.3 Product Landscape
    • 6.14.4 SWOT Analysis
  • 6.15 Doctor's Best
    • 6.15.1 Business Overview
    • 6.15.2 Financial Data
    • 6.15.3 Product Landscape
    • 6.15.4 SWOT Analysis
    • 6.15.5 Strategic Outlook
  • 6.16 Xiamen Kingdomway Group
    • 6.16.1 Business Overview
    • 6.16.2 Financial Data
    • 6.16.3 Product Landscape
    • 6.16.4 SWOT Analysis
  • 6.17 GNC Holdings, Inc.
    • 6.17.1 Business Overview
    • 6.17.2 Financial Data
    • 6.17.3 Product Landscape
    • 6.17.4 SWOT Analysis
  • 6.18 Nordic Naturals, Inc.
    • 6.18.1 Business Overview
    • 6.18.2 Financial Data
    • 6.18.3 Product Landscape
    • 6.18.4 SWOT Analysis

Chapter 7 Potential Customers

  • 7.1 Merck & Co.
    • 7.1.1 Business Overview
    • 7.1.2 Financial Data
    • 7.1.3 Product Landscape
  • 7.2 Abbott Laboratories
    • 7.2.1 Business Overview
    • 7.2.2 Financial Data
    • 7.2.3 Product Landscape
  • 7.3 Sun Pharmaceutical Industries Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Data
    • 7.3.3 Product Landscape
  • 7.4 Pfizer
    • 7.4.1 Business Overview
    • 7.4.2 Financial Data
    • 7.4.3 Product Landscape
  • 7.5 Sanofi
    • 7.5.1 Business Overview
    • 7.5.2 Financial Data
    • 7.5.3 Product Landscape
  • 7.6 Bristol Myers Squibb
    • 7.6.1 Business Overview
    • 7.6.2 Financial Data
    • 7.6.3 Product Landscape
  • 7.7 Novartis
    • 7.7.1 Business Overview
    • 7.7.2 Financial Data
    • 7.7.3 Product Landscape
  • 7.8 Johnson & Johnson
    • 7.8.1 Business Overview
    • 7.8.2 Financial Data
    • 7.8.3 Product Landscape
  • 7.9 GlaxoSmithKline
    • 7.9.1 Business Overview
    • 7.9.2 Financial Data
    • 7.9.3 Product Landscape
  • 7.10 Unilever
    • 7.10.1 Business Overview
    • 7.10.2 Financial Data
    • 7.10.3 Product Landscape
  • 7.11 Avon Products, Inc
    • 7.11.1 Business Overview
    • 7.11.2 Financial Data
    • 7.11.3 Product Landscape
  • 7.12 Beiersdorf
    • 7.12.1 Business Overview
    • 7.12.2 Financial Data
    • 7.12.3 Product Landscape
  • 7.13 Henkel AG & Co., KGaA
    • 7.13.1 Business Overview
    • 7.13.2 Financial Data
    • 7.13.3 Product Landscape
  • 7.14 Oriflame Holding AG
    • 7.14.1 Business Overview
    • 7.14.2 Financial Data
    • 7.14.3 Product Landscape
  • 7.15 The Estee Lauder Companies Inc.
    • 7.15.1 Business Overview
    • 7.15.2 Financial Data
    • 7.15.3 Product Landscape
  • 7.16 Yves Rocher
    • 7.16.1 Business Overview
    • 7.16.2 Financial Data
    • 7.16.3 Product Landscape
  • 7.17 Shiseido Company, Limited
    • 7.17.1 Business Overview
    • 7.17.2 Financial Data
    • 7.17.3 Product Landscape
  • 7.18 Bluebonnet Nutrition
    • 7.18.1 Business Overview
    • 7.18.2 Financial Data
    • 7.18.3 Product Landscape
  • 7.19 Barlean's
    • 7.19.1 Business Overview
    • 7.19.2 Financial Data
    • 7.19.3 Product Landscape
  • 7.20 Natural Factors
    • 7.20.1 Business Overview
    • 7.20.2 Financial Data
    • 7.20.3 Product Landscape
  • 7.21 LifeExtension
    • 7.21.1 Business Overview
    • 7.21.2 Financial Data
    • 7.21.3 Product Landscape
Product Code: 741

Data Tables

  • TABLE 1 Global coenzyme Q10 industry 3600 synopsis, 2023 - 2032
  • TABLE 2 Global coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 3 Global coenzyme Q10 market volume, by region, 2018 - 2032, (Tons)
  • TABLE 4 Global coenzyme Q10 market revenue, by region, 2018 - 2032, (USD Million)
  • TABLE 5 Global coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 6 Global coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 7 Vendor matrix
  • TABLE 8 CoQ10 distribution channel analysis
  • TABLE 9 Industry impact forces
  • TABLE 10 Top players overview
  • TABLE 11 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 12 Global coenzyme Q10 market volume from pharmaceutical application, by region, 2018 - 2032, (Tons)
  • TABLE 13 Global coenzyme Q10 market revenue from pharmaceutical application, by region, 2018 - 2032, (USD Million)
  • TABLE 14 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 15 Global coenzyme Q10 market volume from dietary supplements application, by region, 2018 - 2032, (Tons)
  • TABLE 16 Global coenzyme Q10 market revenue from dietary supplements application, by region, 2018 - 2032, (USD Million)
  • TABLE 17 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 18 Global coenzyme Q10 market volume from cosmetics application, by region, 2018 - 2032, (Tons)
  • TABLE 19 Global coenzyme Q10 market revenue from cosmetics application, by region, 2018 - 2032, (USD Million)
  • TABLE 20 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 21 Global coenzyme Q10 market volume from other application, by region, 2018 - 2032, (Tons)
  • TABLE 22 Global coenzyme Q10 market revenue from other application, by region, 2018 - 2032, (USD Million)
  • TABLE 23 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 24 North America coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 25 North America coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 26 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 27 U.S. coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 28 U.S. coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 29 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 30 Canada coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 31 Canada coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 32 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 33 Europe coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 34 Europe coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 35 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 36 Germany coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 37 Germany coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 38 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 39 UK coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 40 UK coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 41 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 42 France coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 43 France coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 44 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 45 Italy coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 46 Italy coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 47 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 48 Russia coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 49 Russia coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 50 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 51 Poland coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 52 Poland coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 53 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 54 Asia Pacific coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 55 Asia Pacific coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 56 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 57 China coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 58 China coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 59 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 60 India coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 61 India coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 62 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 63 Japan coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 64 Japan coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 65 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 66 LATAM coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 67 LATAM coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 68 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 69 Brazil coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 70 Brazil coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 71 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 72 Mexico coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 73 Mexico coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 74 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 75 MEA coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 76 MEA coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 Global heart conditions & statistics, 2019, (% share)
  • FIG. 2 Global cosmetic market share by category, 2019, (% share)
  • FIG. 3 Europe cosmetic market by country, 2019, (USD billion)
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry ecosystem analysis
  • FIG. 6 Global CoQ10 market estimates and forecast, 2018 - 2032 (Tons) (USD Million)
  • FIG. 7 Coenzyme Q10 technology landscape
  • FIG. 8 Lactobacilli price trends (USD/kilo)
  • FIG. 9 North America cosmetics market, 2018, (USD Million)
  • FIG. 10 Europe diabetes data, 2019, (% share)
  • FIG. 11 Europe attributable factors risk factors for CVD, 2020, (% share)
  • FIG. 12 Asia Pacific pharmaceutical market, 2017-2031, (USD Billion)
  • FIG. 13 Growth potential analysis, 2022
  • FIG. 14 Porter's analysis
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 PESTEL analysis
  • FIG. 17 SWOT Analysis, Kaneka Corporation
  • FIG. 18 SWOT Analysis, DSM
  • FIG. 19 SWOT Analysis, SourceOne Global Partners
  • FIG. 20 SWOT Analysis, Healthy Origins
  • FIG. 21 SWOT Analysis, Vitamin Shoppe, Inc
  • FIG. 22 SWOT Analysis, Nature's Bounty Co
  • FIG. 23 SWOT Analysis, Pharmavite LLC
  • FIG. 24 SWOT Analysis, Quten Research Institute
  • FIG. 25 SWOT Analysis, Tishcon Corp
  • FIG. 26 SWOT Analysis, Country Life, LLC
  • FIG. 27 SWOT Analysis, Natural Organics
  • FIG. 28 SWOT Analysis, Jarrow Formulas
  • FIG. 29 SWOT Analysis, NOW Foods
  • FIG. 30 SWOT Analysis, Pharma Nord
  • FIG. 31 SWOT Analysis, Doctor's Best, Inc
  • FIG. 32 SWOT Analysis, Xiamen Kingdomway Group
  • FIG. 33 SWOT Analysis, GNC Holdings, Inc
  • FIG. 34 SWOT Analysis, Nordic Naturals, Inc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!